Long-Term Study Links Chemotherapy Drug Cisplatin to Hearing Loss in Testicular Cancer Survivors
A 14-year study of testicular cancer survivors indicates that the chemotherapy drug cisplatin significantly increases patients’ long-term risk of hearing loss. Cisplatin has been a cornerstone of cancer chemotherapy for decades, used to treat a variety of cancers, including bladder, lung, neck, and testicular tumors. as reported by U.S News. Dr. Robert Frisina, co-author of…